A carregar...
Early experience with remdesivir in SARS-CoV-2 pneumonia
At present, there is no definitive antiviral treatment for coronavirus disease 2019 (COVID-19). We describe our early experience with remdesivir in four critically ill COVID-19 patients. Patients received a 200 mg loading dose, followed by 100 mg daily intravenously for up to 10 days. All patients h...
Na minha lista:
| Publicado no: | Infection |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7229436/ https://ncbi.nlm.nih.gov/pubmed/32418190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s15010-020-01448-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|